ArticleAnnals of surgical oncology2022
Initial Experience Using Magseed for Breast Lesion Localization Compared With Wire-Guided Localization: Analysis of Volume and Margin Clearance Rates.
Article in Annals of surgical oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.
- Wire-Free, Nonradioactive Localization Techniques to Guide Surgical Excision of Nonpalpable Breast Tumours: A Health Technology Assessment.Ontario health technology assessment series · 2023Pooled it
- Preoperative Magnetic Seed Versus Wire-Guided Localization in the Treatment of Nonpalpable Breast Cancer: A Retrospective Observational Study at a Tertiary Care Center.International journal of breast cancer · 2025Article
- Breast-Conserving Surgery Guided with Magnetic Seeds vs. Wires: A Single-Institution Experience.Cancers · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDetection of nonpalpable lesions requiring surgical intervention has increased during the past several decades. Techniques have evolved to help surgeons locate lesions in the operating room. Disadvantages of wire localization has led to the use of new approaches for surgical guidance. Magnetic seeds have been suggested to improve workflow and cosmetic result.
methodsThis retrospective cohort study analyzed consecutive patients undergoing lumpectomy or excisional biopsy with the guidance of wire localization or magnetic seeds. The optimal and total resected volumes were calculated from pathology records, and the calculated resection volumes were compared by localization approach. Margin positivity and need for reoperation were reviewed and compared.
resultsEach group included 148 patients. The majority were treated with lumpectomy and did not undergo preoperative chemotherapy. The operative characteristics did not vary by group. Considering only lumpectomy cases, total volume resected (13.7 vs. 17.1; p = 0.003) and calculated resection ratios (1.8 vs. 2.5; p = 0.02) were significantly lower in the magnetic seed group. The rates of positive margins (10% vs. 14%) and reoperation (12.8% vs. 17.3%) were non-significantly lower than in the wire localization cases.
conclusionsMagnetic seeds were successfully used for lesion localization in this cohort. Pathologic examination of specimens suggested that the surgeons were able to remove closer to optimal volumes of tissue than those using wire-guided intervention. Removal of less tissue did not result in higher rates of margin positivity or a need for re-intervention to achieve negative margin status. Magnetic seeds are a feasible and non-inferior approach that overcomes many drawbacks of other localization methods.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.